Skip to main content
Premium Trial:

Request an Annual Quote

Clontech's Smart-Seq v4 Ultra Low Input RNA Kit for the Fluidigm C1 System

Fluidigm and Takara Bio subsidiary Clontech Laboratories have jointly launched the Smart-Seq v4 Ultra Low Input RNA kit for the Fluidigm C1 system. The kit is available for four and 10 integrated fluidic circuits, and allows for high-quality cDNA synthesis starting from 96 single cells that have been isolated and processed with the C1 system. Like Clontech's other Smart-Seq v4 products, this kit provides higher sensitivity, more accurate expression data for genes with high GC content, and higher yield of cDNA compared to existing chemistry, the company said.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.